Study title:
J Nucl Med. 2001 Aug;42(8):1139-43.
Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of
patients with malignant lymphoma.
SchÃder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J,
Czernin J.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|